| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000446376 |
| P698 | PubMed publication ID | 27166158 |
| P2093 | author name string | Joris R Delanghe | |
| Marijn M Speeckaert | |||
| Reinhart Speeckaert | |||
| Stéphanie Desmedt | |||
| Valérie Desmedt | |||
| P433 | issue | 5 | |
| P921 | main subject | renal pathology | Q3347171 |
| P304 | page(s) | 305-317 | |
| P577 | publication date | 2016-05-12 | |
| P1433 | published in | American Journal of Nephrology | Q15762667 |
| P1476 | title | Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander | |
| P478 | volume | 43 |
| Q57456610 | Bioactive Compounds for the Treatment of Renal Disease |
| Q95582601 | Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study |
| Q47414287 | Elevated High Sensitivity C-Reactive Protein Increases the Risk of Microalbuminuria in Subjects With Cardiovascular Disease Risk Factors |
| Q57807540 | Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery |
| Q55259032 | Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma. |
| Q88983378 | GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD |
| Q47653100 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update |
| Q40239271 | Galectin-3 Is a Target for Proteases Involved in the Virulence of Staphylococcus aureus |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q64097454 | Galectin-3 as a prognostic biomarker for diabetic nephropathy |
| Q50126684 | Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus |
| Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
| Q89486528 | High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients |
| Q37685430 | Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. |
| Q40060474 | Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease |
| Q33604689 | Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients |
| Q50895945 | Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. |
Search more.